NCT03690388 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 125
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 187
- units
- Participants
- groups
- description
- cabozantinib (60 mg) once daily orally (qd) Cabozantinib: Tablets containing 60-mg or 20-mg cabozantinib once daily orally.
- id
- BG000
- title
- Cabozantinib
- description
- placebo once daily orally (qd) Placebo: Tablets containing placebo equivalent of 60-mg or 20-mg cabozantinib once daily orally.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 91
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 63
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 96
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 32
- upper Limit
- 85
- value
- 65
- group Id
- BG001
- lower Limit
- 37
- upper Limit
- 81
- value
- 66
- group Id
- BG002
- lower Limit
- 32
- upper Limit
- 85
- value
- 66
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 102
- title
- Female
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 85
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 27
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 95
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 148
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 12
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 34
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 90
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 131
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 16
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Hong Kong
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 19
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Czechia
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Thailand
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 11
- title
- Russia
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Netherlands
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- South Korea
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 15
- title
- Brazil
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 11
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Croatia
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 118
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Receipt of prior lenvatinib
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 125
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 187
- units
- Participants
- groups
- description
- cabozantinib (60 mg) once daily orally (qd) Cabozantinib: Tablets containing 60-mg or 20-mg cabozantinib once daily orally.
- id
- BG000
- title
- Cabozantinib
- description
- placebo once daily orally (qd) Placebo: Tablets containing placebo equivalent of 60-mg or 20-mg cabozantinib once daily orally.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 91
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 63
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 96
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 32
- upper Limit
- 85
- value
- 65
- group Id
- BG001
- lower Limit
- 37
- upper Limit
- 81
- value
- 66
- group Id
- BG002
- lower Limit
- 32
- upper Limit
- 85
- value
- 66
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 102
- title
- Female
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 85
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 27
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 95
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 148
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 12
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 34
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 90
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 131
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 16
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Hong Kong
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 19
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Czechia
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Thailand
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 11
- title
- Russia
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Netherlands
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- South Korea
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 15
- title
- Brazil
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 11
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Croatia
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 118
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Receipt of prior lenvatinib
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle